Conclusion

CONCLUSION

Though relatively rare, idiosyncratic haematological ADR are potentially life threatening. Any patient receiving drug therapy who presents with symptoms of anaemia, unusual infection or bleeding should have simple screening tests including a FBC performed. Significant cytopenias or coagulation derangement should prompt the consideration of the possibility of ADR and discontinuation or substitution of potentially implicated agents. Patients should be investigated and managed by staff with appropriate expertise and facil-ities for relevant supportive care.